🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

18 recruiting trials

for Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)

Real Life Study of Biologicals in Patients With Severe CRSwNP NCT05938972n/a1 site📍 Ghent University Hospital, Ghent · Tests: Mepolizumab Prospective, Non-interventional Single-arm Study With Tezepelumab to Investigate the Change in Clinical and Patient-reported Outcomes in Patients With CRSwNP in Real-world (PETRICHOR) NCT07633158n/a19 sites📍 Berlin📍 Bochum📍 Braunschweig AstraZeneca A Study to Assess the Efficacy and Safety of GSK5784283 (Felcorekibart) in Participants With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) NCT07782970Phase 33 sites📍 Los Angeles📍 Tulsa📍 San Juan GlaxoSmithKline · Tests: GSK5784283, Placebo, Standard of Care Implementation of a Joint Pulmonologist and ENT Consultation in the Care Pathway of Patients Suffering From Asthma and Chronic Rhinosinusitis With Nasal Polyposis: Effectiveness Compared With Consultations by Specialty (CON-PO Study). NCT07134686NA1 site📍 Marseille Assistance Publique Hopitaux De Marseille · Tests: Joint consultation, Mucus sampling, Nasal brushing A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP) NCT06338995Phase 3202 sites📍 Birmingham📍 Birmingham📍 Huntsville Eli Lilly and Company · Tests: LY3650150, Placebo, Standard therapy for INCS Olfactory Cleft Obstruction and Electrophysiological Field Potentials Predict Olfactory Restoration by Dupilumab in CRSwNP Patients. NCT06892704n/a1 site📍 Chicago Northwestern University · Tests: Dupilumab - Standard Dose Real-Time Diagnosis of Eosinophilic Nasal Polyps Using High-Sensitivity Spectroscopy NCT07125586NA1 site📍 Qingdao The Affiliated Hospital of Qingdao University · Tests: High-Sensitivity Spectroscopy with Autofluorescence for eCRSwNP Diagnosis Interleukin-4Ra Blockade by Dupilumab Decreases Staphylococcus Colonization and Increases Microbial Diversity in CRSwNP NCT05094570Phase 41 site📍 Charlottesville University of Virginia · Tests: Dupilumab Prefilled Syringe A Study to Investigate NPS and Symptoms in Chinese Adult Participants With CRSwNP Initiating Treatment With Tezepelumab NCT07520162Phase 334 sites📍 Beijing📍 Beijing📍 Bengbu AstraZeneca · Tests: Tezepelumab Metabolic and Immunologic Biomarkers in Chronic Rhinosinusitis With Nasal Polyps NCT07860411n/a1 site📍 Sanliurfa Harran University · Tests: Nasal polyp tissue and blood sampling, Nasal mucosa and blood sampling A Study of BBT002 in Healthy Volunteers (HVs) and in Patients With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) With or Without Comorbid Asthma NCT07436949Phase 1, Phase 212 sites📍 Beijing📍 Guangzhou📍 Changsha Bambusa Therapeutics · Tests: BBT002, Placebo Cognitive and Immunologic Profiles of Patients With Olfactory Dysfunction After Smell Training NCT07681973NA1 site📍 Cleveland The Cleveland Clinic · Tests: Smell Training ReAl-woRld Evaluation of tEzepelumab for Chronic rhinoSinusitis With Nasal Polyps in Russia NCT07399665n/a10 sites📍 Kazan'📍 Kemerovo📍 Krasnoyarsk AstraZeneca Real-life Evaluation of the Efficacy of Biologicals in Chronic Rhinosinusitis With Nasal Polyposis (CRSwNP) NCT06683261n/a8 sites📍 Aalst📍 Bruges📍 Brussels Universitaire Ziekenhuizen KU Leuven · Tests: Omalizumab, Dupilumab, Mepolizumab 100 mg Upper Airway Inflammation and Olfaction: Mechanisms of Loss and Recovery NCT06776042NA1 site📍 Brussels Cliniques universitaires Saint-Luc- Université Catholique d… · Tests: Nasal brushing of the olfactory cleft, Smell testing A Study to Assess the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) NCT07782957Phase 34 sites📍 Sherman Oaks📍 Greenville📍 Plano GlaxoSmithKline · Tests: GSK5784283, Placebo, Standard of Care Effect of Dupilumab on Nasal Epithelial Barrier Function in Patients With CRSwNP NCT06398873n/a1 site📍 Vienna Medical University of Vienna · Tests: Dupilumab 300 MG/2 ML Subcutaneous Solution [DUPIXENT] Efficacy and Safety of Depemokimab Monotherapy Without Concomitant Use of Intranasal Corticosteroids (INCS) in Japanese Participants With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) NCT07701967Phase 410 sites📍 Ehime📍 Ehime📍 Fukui GlaxoSmithKline · Tests: Depemokimab
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy